Recent

% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • powderhog2011 powderhog2011 Nov 3, 2012 5:20 PM Flag

    $6 DOLLAR PRICE TARGET!!!

    Biopharma (GALE)

    November 3rd, 2012 - 0 comments - Filed Under - by Jeff Wilder

    Analysts at Maxim Group started coverage on shares of Galena Biopharma (NASDAQ: GALE) in a research report issued to clients and investors on Friday. The firm set a “buy” rating and a $5.00 price target on the stock.

    A number of other firms have also recently commented on GALE. Analysts at McNicoll Lewis & Vlak initiated coverage on shares of Galena Biopharma in a research note to investors on Thursday, October 25th. They set a “buy” rating and a $6.00 price target on the stock. Separately, analysts at MLV Capital initiated coverage on shares of Galena Biopharma in a research note to investors on Thursday, October 25th. They set a “buy” rating and a $6.00 price target on the stock. Finally, analysts at Cantor Fitzgerald reiterated a “buy” rating on shares of Galena Biopharma in a research note to investors on Wednesday, August 15th. They now have a $4.00 price target on the stock.

    Shares of Galena Biopharma opened at 2.2347 on Friday. Galena Biopharma has a 52 week low of $0.36 and a 52 week high of $3.54. The company’s market cap is $150.1 million.

    Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using RNAi-targeted and immunotherapy technologies.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GALE
1.61+0.04(+2.55%)Jun 1 4:00 PMEDT